Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis
- PMID: 7569976
- DOI: 10.1126/science.270.5234.286
Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis
Abstract
Glucocorticoids are among the most potent anti-inflammatory and immunosuppressive agents. They inhibit synthesis of almost all known cytokines and of several cell surface molecules required for immune function, but the mechanism underlying this activity has been unclear. Here it is shown that glucocorticoids are potent inhibitors of nuclear factor kappa B (NF-kappa B) activation in mice and cultured cells. This inhibition is mediated by induction of the I kappa B alpha inhibitory protein, which traps activated NF-kappa B in inactive cytoplasmic complexes. Because NF-kappa B activates many immunoregulatory genes in response to pro-inflammatory stimuli, the inhibition of its activity can be a major component of the anti-inflammatory activity of glucocorticoids.
Comment in
-
How the glucocorticoids suppress immunity.Science. 1995 Oct 13;270(5234):232-3. doi: 10.1126/science.270.5234.232. Science. 1995. PMID: 7569969 No abstract available.
Similar articles
-
How the glucocorticoids suppress immunity.Science. 1995 Oct 13;270(5234):232-3. doi: 10.1126/science.270.5234.232. Science. 1995. PMID: 7569969 No abstract available.
-
Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids.Science. 1995 Oct 13;270(5234):283-6. doi: 10.1126/science.270.5234.283. Science. 1995. PMID: 7569975
-
Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50.J Immunol. 1998 Dec 1;161(11):6084-92. J Immunol. 1998. PMID: 9834092
-
Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors.J Neuroimmunol. 2000 Sep 1;109(1):16-22. doi: 10.1016/s0165-5728(00)00297-6. J Neuroimmunol. 2000. PMID: 10969176 Review.
-
Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids.J Mol Endocrinol. 2002 Apr;28(2):69-78. doi: 10.1677/jme.0.0280069. J Mol Endocrinol. 2002. PMID: 11932204 Review.
Cited by
-
VoPo leverages cellular heterogeneity for predictive modeling of single-cell data.Nat Commun. 2020 Jul 27;11(1):3738. doi: 10.1038/s41467-020-17569-8. Nat Commun. 2020. PMID: 32719375 Free PMC article.
-
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma.J Neuroinflammation. 2013 Feb 1;10:20. doi: 10.1186/1742-2094-10-20. J Neuroinflammation. 2013. PMID: 23374874 Free PMC article.
-
Inhibition of microglial nitric oxide production by hydrocortisone and glucocorticoid precursors.Neurochem Res. 2000 Jul;25(7):903-8. doi: 10.1023/a:1007511221666. Neurochem Res. 2000. PMID: 10959485
-
Regulation of inducible gene expression by the transcription factor NF-kappaB.Immunol Res. 1999;19(2-3):183-9. doi: 10.1007/BF02786486. Immunol Res. 1999. PMID: 10493172 Review.
-
Targeting TNF-alpha with a tetravalent mini-antibody TNF-TeAb.Biochem J. 2007 Sep 1;406(2):237-46. doi: 10.1042/BJ20070149. Biochem J. 2007. PMID: 17472572 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical